MedPath
NMPA Approval

Tiotropium Bromide Powder for Inhalation

国药准字HJ20140933

May 13, 2024

H20140933

Drug Information

噻托溴铵吸入粉雾剂

思力华

吸入粉雾剂

每粒含噻托溴铵18μg(按C₁₉H₂₂NO₄S₂计),递送剂量为10.2μg(按 C₁₉H₂₂NO₄S₂计)

化学药品

May 13, 2024

May 12, 2029

Company Information

Applicant Company

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany

Manufacturing Company

Binger Straβe 173, 55216 Ingelheim am Rhein, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

噻托溴铵吸入粉雾剂 - NMPA 批准文号 | MedPath